This monograph investigates the efficacy and mechanisms of Bacillus Calmette-Guérin (BCG) in treating superficial bladder cancer. It details the current understanding of BCG's antitumor effects, exploring optimal treatment protocols including schedules, strains, and dosages. The work also addresses the placement of this immunotherapy and provides risk-to-benefit analyses for its application, alongside research into animal tumor systems and human studies on antitumor activity and mechanisms of action.

This volume is a specialized monograph presenting the latest thinking on BCG treatment for bladder cancer. It is likely to be regarded as a key reference for oncologists and urologists involved in cancer research and treatment. The detailed examination of mechanisms, protocols, and analyses suggests a text aimed at professionals seeking in-depth knowledge. Its focus on specific research findings and clinical application indicates its value within the medical research community.